GlobeNewswire·Nov 9, 2026, 6:54 AM ET

LifeStance Health Group Announces Launch of Secondary Public Offering

LifeStance Health Group announced that certain stockholders intend to offer 45,000,000 shares of common stock under a shelf registration statement filed with the SEC.
The selling stockholders will receive all proceeds from the offering, while LifeStance will not sell any shares or receive any funds.
LifeStance authorized the concurrent purchase of 2,000,000 shares from underwriters for a repurchase, subject to the offering's completion.
The repurchase price will match the price payable to selling stockholders, with no underwriting fees applied to the repurchased shares.
Barclays and J.P. Morgan are acting as underwriters for the offering.
The automatic shelf registration statement became effective upon filing on May 21, 2024.
LifeStance employs over 8,800 mental health professionals across 35 states with more than 550 centers.
The press release includes forward-looking statements regarding the offering terms, risks, reimbursement rates, clinician recruitment, regulatory compliance, data security, and financial performance.